Ability of procalcitonin to distinguish between bacterial and nonbacterial infection in severe acute exacerbation of chronic obstructive pulmonary syndrome in the ICU
Cédric Daubin, François Fournel, Fabrice Thiollière, Fabrice Daviaud, Michel Ramakers, Andréa Polito, Bernard Flocard, Xavier Valette, Damien Du Cheyron, Nicolas Terzi, Muriel Fartoukh, Stephane Allouche, Jean-Jacques Parienti, from the PROCALCIVIR and BPCTrea study group;Cédric Daubin;François Fournel;Fabrice Thiollière;Fabrice Daviaud;Michel Ramakers;Andréa Polito;Bernard Flocard;Xavier Valette;Damien Du Cheyron;Nicolas Terzi;Muriel Fartoukh;Stephane Allouche;Jean-Jacques Parienti;from the PROCALCIVIR and BPCTrea study group;
annals of intensive care2021Vol. 11pp. -
135
group2021annalsability
Abstract
To assess the ability of procalcitonin (PCT) to distinguish between bacterial and nonbacterial causes of patients with severe acute exacerbation of COPD (AECOPD) admitted to the ICU, we conducted a retrospective analysis of two prospective studies including ...